EN | TR
E-ISSN: 3061-9947
Feared complication of malignancy: Venous thromboembolism
PDF
Cite
Share
Request
Original Article
VOLUME: 50 ISSUE: 3
P: 195-200
2017

Feared complication of malignancy: Venous thromboembolism

Acta Haematol Oncol Turc 2017;50(3):195-200
DOI: 10.5505/aot.2017.38258
Funda Karaduman Yalçın
Ayşegül Şentürk
Ayşegül Karalezli
Ayşenur Soytürk
Elif Babaoğlu
Hatice Canan Hasanoğlu
1. Department of Chest Diseases,Boyabat 75th State Hospital, Sinop, Turkey
2. Department of Chest Diseases, Ataturk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey
3. Department of Chest Diseases, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey
4. Department of Anesthesia and Reanimation, Faculty of Medicine, Uludag University, Bursa, Turkey
5. Department of Chest Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey
6.
No information available.
No information available
Received Date: 2017-04-09T23:11:58
Accepted Date: 2017-12-19T11:15:19
PDF
Cite
Share
Request

Abstract

INTRODUCTION

In this study we aimed to evaluate the relationship between the location and histological structure of primary malignancy and pulmonary thromboembolism (PTE) in patiens both having malignancy and pulmonary thromboembolism.

METHODS

Forty- two (42) patients followed by the diagnosis of both malignancy and PTE were enrolled in our study between May 2010- July 2013. We assessed our patients according to ages, genders, comorbidity and smoking habits and malignancy according to the location of malignancy, pathological subtypes, metastases and the duration of the initial diagnosis.

RESULTS

Of the whole 42 patients with malignancy and PTE, 15 patients were female (35,7%), 27 patients were male (64,3%). The mean age were 60,4 ± 14 (24-86). 19 patients (45,2%) were having pulmonary, 22 patiens (52,4%) were having extrapulmonary malignancy. The distrubition of pulmonary malignancy were as follows; adenocarcinoma (13 (30,9%)), squamous cell (4, (9,5%)) and small cell carcinoma (2 (4,7%)). The distrubition of extrapulmonary malignancy were as follows; gastrointestinal tract malignancies (9 (21,4%)), malignancy of the genitourinary system 8 (19%), head and neck tumors (3 (7,1%)), haematological malignancy (2 (7,1%)) and metastatic carcinoma of unknown primary (1(2,3%)). The lower extremity thrombosis in 25 patients (59,5%), the upper extremity thrombosis in 2 patients (4,8%), both upper and lower extremities thrombosis in 2 patients (4,8%) were detected by the examination of the venous Doppler ultrasound.

DISCUSSION AND CONCLUSION

Thromboembolic diseases are known as one of the major causes of mortality in cancer patients. It has been shown in the previously studies that pulmonary thromboembolism has an enhancing effect to mortality in cancer patients. Therefore, in the presence of clinical suspicion of PTE, it must be diagnosed and treated as soon as possible. Patients of whom are diagnosed as PTE should be reconsidered and further investigations should be performed because of the probability of an underlying malignancy.